Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

about

Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.

P2860

Q50034331-C51199B3-734D-4E21-8DF7-74BC3645B608

P2860

Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

Item

http://www.wikidata.org/entity/Q40374977

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Everolimus-Eluting Stent for P ...... al Arterial Occlusive Disease.

@en

type

Item

label

Everolimus-Eluting Stent for P ...... al Arterial Occlusive Disease.

@en

prefLabel

Everolimus-Eluting Stent for P ...... al Arterial Occlusive Disease.

@en

P1476

Everolimus-Eluting Stent for P ...... al Arterial Occlusive Disease.

@en

P2093

Alessia Giaquinta

http://www.w3.org/2001/XMLSchema#string

Ardita Vincenzo

http://www.w3.org/2001/XMLSchema#string

Ester De Marco

http://www.w3.org/2001/XMLSchema#string

Massimiliano Veroux

http://www.w3.org/2001/XMLSchema#string

Pierfrancesco Veroux

http://www.w3.org/2001/XMLSchema#string

P2860

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.

Endovascular therapy for critical limb ischemia.

Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial

Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results.

Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.

Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.

Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial.

A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial.

First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome.

Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial.

P304

60-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1538574416689429

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28100126

http://www.w3.org/2001/XMLSchema#string

Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

about

P2860

P2860

Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698